Clinical Research Directory
Browse clinical research sites, groups, and studies.
Retrospective WGS Study
Sponsor: The Wellcome Sanger Institute
Summary
This retrospective case series reviews clinical notes to assess whether NHS whole genome sequencing provides tangible benefits for paediatric tumours.
Official title: Assessing the Clinical Benefits of Whole Genome Sequencing for Children With Neoplasms
Key Details
Gender
All
Age Range
0 Years - 21 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2022-09-22
Completion Date
2027-03-31
Last Updated
2025-02-11
Healthy Volunteers
No
Conditions
Interventions
No intervention
As per widely adopted clinical research practice for case reviews of de-identified, anonymised data, no explicit consent of participants (or their legal guardians) would be required for this study other than the consent they provided at biopsy (from which the whole genome sequencing data is derived) for researchers to access their notes (as documented on hospital consent form).
Locations (1)
Wellcome Sanger Institute
Cambridge, United Kingdom